Daniel is a public affairs specialist with a decade’s experience working in agency and in-house. In healthcare, his area of expertise is market access, particularly in cancer, where he has supported and led successful campaigns in the Westminster, Holyrood and European parliaments.
Prior to its acquisition by Four Communications, Daniel was a Director at ICG. His clients have included Bristol-Myers Squibb, Sanofi, Myeloma UK, International SOS and Universities UK. He joined ICG in 2009 from the policy and government affairs team at global pharmaceutical company Merck Sharp & Dohme where he briefed senior management on key NHS and industry policy developments.